Cargando…
Chemerin levels in chronic kidney disease: A systematic review and meta-analysis
INTRODUCTION: Chemerin as an inflammatory biomarker has gained attention in its biomarker capability. Several studies measured its levels in chronic kidney disease (CKD), as one of the common non-communicable causes of mortality and morbidity. Hence, this systematic review and meta-analysis aimed to...
Autores principales: | Behnoush, Amir Hossein, Shobeiri, Parnian, Bahiraie, Pegah, Amirkhani, Nikan, Khalaji, Amirmohammad, Peiman, Soheil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907439/ https://www.ncbi.nlm.nih.gov/pubmed/36761204 http://dx.doi.org/10.3389/fendo.2023.1120774 |
Ejemplares similares
-
High circulating endocan in chronic kidney disease? A systematic review and meta-analysis
por: Khalaji, Amirmohammad, et al.
Publicado: (2023) -
Composite lipid indices in patients with obstructive sleep apnea: a systematic review and meta-analysis
por: Behnoush, Amir Hossein, et al.
Publicado: (2023) -
Aspirin and P2Y12 inhibitors in treating COVID-19
por: Khalaji, Amirmohammad, et al.
Publicado: (2023) -
Adjunctive therapy with lipid-lowering agents in COVID-19: a systematic review and meta-analysis of randomized controlled trials
por: Khalaji, Amirmohammad, et al.
Publicado: (2023) -
Endocan in prediabetes, diabetes, and diabetes-related complications: a systematic review and meta-analysis
por: Khalaji, Amirmohammad, et al.
Publicado: (2023)